Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1987 Jul;56(1):65–67. doi: 10.1038/bjc.1987.155

Serum neuron-specific enolase in children's cancer.

E H Cooper, J Pritchard, C C Bailey, J Ninane
PMCID: PMC2001673  PMID: 3476145

Abstract

To test its diagnostic potential and sensitivity in paediatric malignancy, serum NSE was measured at diagnosis in 191 children with solid tumours and 25 with acute leukaemia. In stages I + II, III + IV and IVs neuroblastoma median levels were 18.0, 91.0 and 24.0 ng ml-1 respectively. For Wilms' patients, median values for stages I, II, III and IV disease were 16.6, 18.0, 29.0 and 47.0 ng ml-1 respectively. High levels of NSE were also found in patients with other types of tumour. Children in clinical remission after treatment for neuroblastoma invariably had normal NSE levels (mean +/- s.d. = 9.2 +/- 3.0 ng ml-1) even though the majority had radiologically identifiable residual disease. The values rose when relapse was radiologically or clinically obvious. We conclude (a) that, though levels of greater than 100 ng ml-1 are highly suggestive of advanced neuroblastoma, caution should be exercised in using serum NSE as a diagnostic test in children with cancer and (b) that serum NSE levels are not a sensitive index of residual neuroblastoma in patients, with initially elevated levels, that are receiving treatment.

Full text

PDF
65

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beemer F. A., Vlug A. M., van Veelen C. W., Rijksen G., Staal G. E. Isozyme pattern of enolase of childhood tumors. Cancer. 1984 Jul 15;54(2):293–296. doi: 10.1002/1097-0142(19840715)54:2<293::aid-cncr2820540218>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  2. D'Angio G. J., Beckwith J. B., Breslow N. E., Bishop H. C., Evans A. E., Farewell V., Fernbach D., Goodwin W. E., Jones B., Leape L. L. Wilm's tumor: an update. Cancer. 1980 Apr 15;45(7 Suppl):1791–1798. [PubMed] [Google Scholar]
  3. Dranoff G., Bigner D. D. A word of caution in the use of neuron-specific enolase expression in tumor diagnosis. Arch Pathol Lab Med. 1984 Jul;108(7):535–535. [PubMed] [Google Scholar]
  4. Evans A. E., D'Angio G. J., Randolph J. A proposed staging for children with neuroblastoma. Children's cancer study group A. Cancer. 1971 Feb;27(2):374–378. doi: 10.1002/1097-0142(197102)27:2<374::aid-cncr2820270221>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  5. Haimoto H., Takashi M., Koshikawa T., Asai J., Kato K. Enolase isozymes in renal tubules and renal cell carcinoma. Am J Pathol. 1986 Sep;124(3):488–495. [PMC free article] [PubMed] [Google Scholar]
  6. Ishiguro Y., Kato K., Ito T., Nagaya M. Determination of three enolase isozymes and S-100 protein in various tumors in children. Cancer Res. 1983 Dec;43(12 Pt 1):6080–6084. [PubMed] [Google Scholar]
  7. Ishiguro Y., Kato K., Ito T., Nagaya M., Yamada N., Sugito T. Nervous system-specific enolase in serum as a marker for neuroblastoma. Pediatrics. 1983 Nov;72(5):696–700. [PubMed] [Google Scholar]
  8. Kivelä T. Neuron-specific enolase in retinoblastoma. An immunohistochemical study. Acta Ophthalmol (Copenh) 1986 Feb;64(1):19–25. doi: 10.1111/j.1755-3768.1986.tb06866.x. [DOI] [PubMed] [Google Scholar]
  9. Marangos P. J., Schmechel D. E., Parma A. M., Goodwin F. K. Developmental profile of neuron-specific (NSE) and non-neuronal (NNE) enolase. Brain Res. 1980 May 19;190(1):185–193. doi: 10.1016/0006-8993(80)91168-3. [DOI] [PubMed] [Google Scholar]
  10. Notomi T., Morikawa J., Kato K., Tsuchida Y., Ohsawa R. Radioimmunoassay development for human neuron-specific enolase: with some clinical results in lung cancers and neuroblastoma. Tumour Biol. 1985;6(1):57–66. [PubMed] [Google Scholar]
  11. Odelstad L., Påhlman S., Läckgren G., Larsson E., Grotte G., Nilsson K. Neuron specific enolase: a marker for differential diagnosis of neuroblastoma and Wilms' tumor. J Pediatr Surg. 1982 Aug;17(4):381–385. doi: 10.1016/s0022-3468(82)80494-6. [DOI] [PubMed] [Google Scholar]
  12. Pritchard J., Cooper E. H., Hamilton S., Bailey C. C., Ninane J. Serum neuron-specific enolase may be raised in children with Wilms' tumour. Lancet. 1987 Jan 10;1(8524):110–110. doi: 10.1016/s0140-6736(87)91952-0. [DOI] [PubMed] [Google Scholar]
  13. Ruibal A., Encabo G., Genollá J., Mañ S., Miralles E. M. La enolasa específica neuronal sérica en pacientes afectos de patología no tumorales. Rev Esp Oncol. 1985;32(1):183–186. [PubMed] [Google Scholar]
  14. Schmechel D. E. Gamma-subunit of the glycolytic enzyme enolase: nonspecific or neuron specific? Lab Invest. 1985 Mar;52(3):239–242. [PubMed] [Google Scholar]
  15. Shafford E. A., Rogers D. W., Pritchard J. Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26. J Clin Oncol. 1984 Jul;2(7):742–747. doi: 10.1200/JCO.1984.2.7.742. [DOI] [PubMed] [Google Scholar]
  16. Triche T. J., Tsokos M., Linnoila R. I., Marangos P. J., Chandra R. NSE in neuroblastoma and other round cell tumors of childhood. Prog Clin Biol Res. 1985;175:295–317. [PubMed] [Google Scholar]
  17. Vinores S. A., Bonnin J. M., Rubinstein L. J., Marangos P. J. Immunohistochemical demonstration of neuron-specific enolase in neoplasms of the CNS and other tissues. Arch Pathol Lab Med. 1984 Jul;108(7):536–540. [PubMed] [Google Scholar]
  18. Zeltzer P. M., Marangos P. J., Evans A. E., Schneider S. L. Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course. Cancer. 1986 Mar 15;57(6):1230–1234. doi: 10.1002/1097-0142(19860315)57:6<1230::aid-cncr2820570628>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  19. Zeltzer P. M., Marangos P. J., Parma A. M., Sather H., Dalton A., Hammond D., Siegel S. E., Seeger R. C. Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study Group. Lancet. 1983 Aug 13;2(8346):361–363. doi: 10.1016/s0140-6736(83)90342-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES